These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 20542641)

  • 1. Activity of topical antimicrobial agents against multidrug-resistant bacteria recovered from burn patients.
    Glasser JS; Guymon CH; Mende K; Wolf SE; Hospenthal DR; Murray CK
    Burns; 2010 Dec; 36(8):1172-84. PubMed ID: 20542641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of multidrug-resistant organisms recovered at a military burn center.
    Keen EF; Robinson BJ; Hospenthal DR; Aldous WK; Wolf SE; Chung KK; Murray CK
    Burns; 2010 Sep; 36(6):819-25. PubMed ID: 20080354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of tigecycline against resistant micro-organisms isolated from burn patients.
    Timurkaynak F; Arslan H; Azap OK; Senger SS; Başaran O; Karaman SO; Haberal M
    Burns; 2008 Nov; 34(7):1033-6. PubMed ID: 18539397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common pathogens in burn wound and changes in their drug sensitivity.
    Rezaei E; Safari H; Naderinasab M; Aliakbarian H
    Burns; 2011 Aug; 37(5):805-7. PubMed ID: 21388742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria.
    Li J; Nation RL; Milne RW; Turnidge JD; Coulthard K
    Int J Antimicrob Agents; 2005 Jan; 25(1):11-25. PubMed ID: 15620821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in bacterial isolates from burn wounds and their antibiograms: a 20-year study (1986-2005).
    Guggenheim M; Zbinden R; Handschin AE; Gohritz A; Altintas MA; Giovanoli P
    Burns; 2009 Jun; 35(4):553-60. PubMed ID: 19167827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigation of 728 strains of infectious bacteria in burn ward and analysis of their antibiotic resistance].
    Deng JJ; Wei LH; Zou FM; Si XQ; Liu G; Gao YX; Liu J
    Zhonghua Shao Shang Za Zhi; 2007 Dec; 23(6):420-3. PubMed ID: 18457252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical Bactroban (mupirocin): efficacy in treating burn wounds infected with methicillin-resistant staphylococci.
    Strock LL; Lee MM; Rutan RL; Desai MH; Robson MC; Herndon DN; Heggers JP
    J Burn Care Rehabil; 1990; 11(5):454-9. PubMed ID: 2123203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NY.
    Landman D; Bratu S; Kochar S; Panwar M; Trehan M; Doymaz M; Quale J
    J Antimicrob Chemother; 2007 Jul; 60(1):78-82. PubMed ID: 17490999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic resistance in clinical isolates of Acinetobacter baumannii, Pseudomonas aeruginosa, and Staphylococcus aureus does not impact sensitivity to human beta defensin 4.
    Supp DM; Gardner J; Klingenberg JM; Neely AN
    Burns; 2009 Nov; 35(7):949-55. PubMed ID: 19501982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical consequences of antimicrobial resistance.
    Rice LB
    Curr Opin Microbiol; 2009 Oct; 12(5):476-81. PubMed ID: 19716760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro efficacy of various topical antimicrobial agents in different time periods from contamination to application against 6 multidrug-resistant bacterial strains isolated from burn patients.
    Hajská M; Slobodníková L; Hupková H; Koller J
    Burns; 2014 Jun; 40(4):713-8. PubMed ID: 24091332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Monitoring of bacteria resistance in burn patients].
    Zhang M; Xu X; Liao P
    Zhonghua Wai Ke Za Zhi; 1999 May; 37(5):278-81. PubMed ID: 11829839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antimicrobial susceptibility pattern of nosocomial gram negative pathogens: results from MYSTIC study in Hacettepe University Adult Hospital (2000-2004)].
    Zarakolu P; Hasçelik G; Unal S
    Mikrobiyol Bul; 2006 Jul; 40(3):147-54. PubMed ID: 17001842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
    Sader HS; Jones RN; Dowzicky MJ; Fritsche TR
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent trend and research issues related to antimicrobial-resistant bacteria].
    Yamane K; Arakawa Y
    Masui; 2010 Jan; 59(1):4-16. PubMed ID: 20077765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era?
    Falagas ME; Bliziotis IA
    Int J Antimicrob Agents; 2007 Jun; 29(6):630-6. PubMed ID: 17306965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The comparison of susceptibility patterns of Gram-negative invasive and non-invasive pathogens in Estonian hospitals.
    Lõivukene K; Kermes K; Sepp E; Adamson V; Mitt P; Jürna M; Mägi H; Kallandi U; Otter K; Naaber P
    Antonie Van Leeuwenhoek; 2006; 89(3-4):367-71. PubMed ID: 16779633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
    Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S
    Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Surveillance of multidrug resistant bacteria in a Tunisian hospital].
    Thabet L; Messadi Aa; Mbarek M; Turki A; Meddeb B; Ben Redjeb S
    Tunis Med; 2008 Nov; 86(11):992-5. PubMed ID: 19213491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.